ML20216J214
| ML20216J214 | |
| Person / Time | |
|---|---|
| Issue date: | 03/09/1998 |
| From: | Shirley Ann Jackson, The Chairman NRC COMMISSION (OCM) |
| To: | Harkin T SENATE |
| Shared Package | |
| ML20216J219 | List: |
| References | |
| NUDOCS 9803230383 | |
| Download: ML20216J214 (2) | |
Text
%g UNITED STATES p[p p [ ()'
p 3
NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 2055 FAX)01
,a e
March 9, 1998
,,,g CHAIRMAN The Honorable Tom Markin United States Senate Washington, D.C. 20510
Dear Senator Harkin:
Thank you for your February 13,1998, letter that urged the Commission to revise its current policy regarding the availability of potassium iodide (KI) for use by the general public in the event of an emergency at a nuclear power plant. Your letter has been included in the record of rulemaking. We have also posted it on the Nuclear Regulatory Commission (NRC) Web Page with other comments from the public received on the petition.
As a result of the petitioner revising his petition, the Commission published a request for public comments in the Federal Reaister on December 17,1997 (62 FR 66038). The comment period was subseouently extended until February 17,1998, by a Federal Reaister notice published on January 21,1998 (63 FR 3052). Following receipt of the staff's recommendation, which we anticipate will be provided in the near future, the Commission will make its decision on the disposition of the petition. We anticipate publishing a revised policy regard'ng the stockpiling and availability of potassium iodide for the general public shortly after the Commission makes its decision on the petition.
For your information, I am enclosing a copy of the January 16,1998, press release that the NRC issued on this matter. The Commission appreciates your interest in this matter.
Sincerely, b
Enclosure:
As stated a
+0 f
9803230383 980309 PDR COMMS NRCC CORRESPONDENCE PDR Coen S
tp://www.ntc. gov /OPA/gmo/nrarev/98-12.htm htt p ://www.nrc. gov /O PA/gm o/nrare v/98-12.htm J,.
i Nuclear Regulatory Commission i
1 Office of Public Affairs i
Washington DC 20555 l
I Telephone: 301/415-8200 - E-mail: opa@nrc. gov No. 98-12 Ja..uaiy 16,1998 j
NRC SEEKS COMMENT ON PETITION FOR RULEMAKING CONCERNING USE OF THYROID PROTECTING DRUG IN EMERGENCY RESPONSE The Nuclear Regulatory Commission is seeking public comment on a petition for rulemaking which asks that the NRC modify its regulation,10 CFR 50.47 (b) (10), to require that nuclear power plant emergency plans consider the inclusion of the use of potassium iodide, a thyroid-protecting drug, for the general public.
The deadline for comments is February 17.
Current Federal policy, published July 24,1985, calls for potassium iodide to be stockpiled for distribution during emergencies to emergency workers and institutionalized persons. If taken in time, the substance blocks most of the thyroid gland's uptake of radioactive iodine. It could thus help reduce the risk of thyroid cancer and other diseases that might othenvise be caused by exposure to radioactive iodine which could be dispersed in a severe nuclear accident.
The Commission last year voted to approve a proposed revision to the current Federal policy which i
would offer to provide funding for states which want to stockpile potassium iodide for use by the general public in the event of a nuclear power plant emergency.
The rulemaking petition now pending before the Commission calls for a change in NRC regulations to s xcify that states and licensees consider the use of potassium iodide, as well as evacuation and s teltering, in the preparation of nuclear power plant emergency plans.
The petition was filed by Peter G. Crane, an NRC staff attorney who took the action as a private citizen.
The original January 16 deadline for comments has been extended by 30 days to allow sufficient time for public comment. Persons wishing copies of the petition may write: Rules and Directives Branch, Division of Administrative Services, Office of Administration, U.S. Nuclear Regulatory Commission, Washington, DC 20555. A copy of the petition and other related documents are also available at the NRC Public Document Room,2120 L Street NW (Lower Level), Washington, DC. The petition also may be accessed on the Internet at htto://rukforum.llnl. gov /cgi-bin /rulemake? source =KI PETITION.
Comments should be mailed to: Secretary, U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001, Attention: Rulemakings and Adjudications Staff. Comments also may be delivered to 11555 Rockville Pike, Rockville, MD, between 7:30 a. m. and 4:15 p. m. on Federal workdays. They also may be provided through the NRC's interactive rulemaking website, which may be reached via the Internet at http://www.nre. gov by looking for rulemaking under the heading "Public Participation and School Programs."
1of2 02/24/98 09:19:32